| scholarly article | Q13442814 |
| P2093 | author name string | Richard Jones | |
| Maureen G Maguire | |||
| Robert S Chapkin | |||
| Gui-Shuang Ying | |||
| Penny A Asbell | |||
| Ann Moser | |||
| Meng C Lin | |||
| Milton M Hom | |||
| Eric J Kuklinski | |||
| DREAM Study Research Group | |||
| Ka Yeun Kim | |||
| P2860 | cites work | Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women | Q24537414 |
| The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis) | Q24649593 | ||
| The fornix in mild cognitive impairment and Alzheimer's disease | Q27015799 | ||
| Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance | Q28246552 | ||
| Importance of dietary gamma-linolenic acid in human health and nutrition | Q28281826 | ||
| Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures | Q28393435 | ||
| Polyunsaturated fatty acids and rheumatoid arthritis | Q32064084 | ||
| The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research | Q33756582 | ||
| HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease | Q33861286 | ||
| The importance of the ratio of omega-6/omega-3 essential fatty acids | Q33962634 | ||
| Changes in human meibum lipid composition with age using nuclear magnetic resonance spectroscopy | Q34101089 | ||
| Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events | Q34229907 | ||
| The core mechanism of dry eye disease is inflammation | Q34510429 | ||
| N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. | Q35171527 | ||
| Analysis of the composition of lipid in human meibum from normal infants, children, adolescents, adults, and adults with meibomian gland dysfunction using ¹H-NMR spectroscopy | Q35247603 | ||
| Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. | Q35507433 | ||
| Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort | Q35879822 | ||
| ω-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye. | Q36872931 | ||
| Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake | Q37147269 | ||
| Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes | Q37155783 | ||
| Omega-6/omega-3 essential fatty acids: biological effects | Q37366317 | ||
| A randomized controlled trial of omega-3 fatty acids in dry eye syndrome | Q37417825 | ||
| Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis | Q37727141 | ||
| TFOS DEWS II pathophysiology report | Q38652987 | ||
| Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older | Q38680274 | ||
| A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease. | Q40462210 | ||
| Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. | Q40948258 | ||
| Associations of erythrocyte ω-3 fatty acids with biomarkers of ω-3 fatty acids and inflammation in breast tissue | Q41618434 | ||
| Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study. | Q42506915 | ||
| Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders | Q43605589 | ||
| Investigational methods for peroxisomal disorders | Q46478829 | ||
| Omega-3 fatty acid supplement prevents development of intracranial atherosclerosis. | Q48451765 | ||
| Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. | Q48517326 | ||
| A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. | Q48613858 | ||
| Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer. | Q50054220 | ||
| Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients. | Q50495766 | ||
| Analysis of inflammatory cytokines in the tears of dry eye patients. | Q54467014 | ||
| Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics | Q57171838 | ||
| Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia | Q58480971 | ||
| High Dietary ω-6:ω-3 PUFA Ratio Is Positively Associated with Excessive Adiposity and Waist Circumference | Q58788632 | ||
| Workshop on the Essentiality of and Recommended Dietary Intakes for Omega-6 and Omega-3 Fatty Acids | Q73053269 | ||
| n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease | Q88350776 | ||
| P921 | main subject | eye disease | Q3041498 |
| P577 | publication date | 2020-02-24 | |
| P1433 | published in | Eye and Contact Lens | Q15765460 |
| P1476 | title | Associations Between Systemic Omega-3 Fatty Acid Levels With Moderate-to-Severe Dry Eye Disease Signs and Symptoms at Baseline in the Dry Eye Assessment and Management Study |
Search more.